康涅狄格州丹伯里和北卡罗来纳州研究三角公园 -业务线)-- IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalized medicines.
Using IQVIA’s E360TM平台,授权的研究人员将对基因组学的基因组学持续措施,取消识别数据具有保护隐私保护的访问,以创建自定义的临床基因组数据集并运行有关基因组学和可观察性状的领先分析。
将IQVIA的主要现实技术和服务专家与英格兰基因组学数据集,网络和基础架构必威官方在线相结合,以生成,组织和增强基因组数据,可以使英国成为生命科学公司投资最有吸引力的地方之一。关于患者人群的更深层次betway必威怎么提款见解和了解潜在治疗价值的更快能力也可能使英国成为分析和科学进步的催化剂。
“IQVIA brings together deep healthcare and life sciences domain expertise to manage and curate real-world data with advanced analytical technologies. Working together, we can unlock the potential of these datasets to advance research and benefit patients in the UK as well as those throughout the world,” said Joanne Hackett, Genomics England’s, chief commercial officer.
Together, IQVIA and Genomics England will enable academic and commercial customers to conduct a wide range of research including: association studies of genomics and observable traits, comparative efficacy and safety trials, and burden-of-illness and discovery analytics using the de-identified data in a secure environment that protects patients’ privacy. Life sciences companies that use IQVIA’s leading clinical and observational research will be able to provide genomic testing to patients in parallel or as part of their clinical programs. This will help advance precision medicine and patients’ access to novel therapies – with the goal of delivering the right drugs to the right patients at the right time.
“Drawing insights from clinical-genomics datasets is the future of real-world research, and we are delighted to work alongside Genomics England as a pioneer in this evolving field,” said Jon Resnick, president, IQVIA Real-World and Analytics Solutions. “Our collaboration advances the analysis of these complex datasets, which could accelerate the discovery of precision therapies, improve access and health outcomes, and deliver upon our Human Data Science vision.”
关于英国基因组学
Genomics England is a company owned by the Department of Health and Social Care and was set up to deliver the 100,000 Genomes Project. This flagship project will sequence 100,000 whole genomes from NHS patients and their families.
英格兰基因组学有四个主要目标:
该项目的重点是罕见疾病及其家人以及常见癌症患者。有关更多信息,请访问www.genomicsengland.co.uk。
关于伊克维亚
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With more than 55,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA是保护个体患者隐私的全球领导者。该公司使用各种各样的隐私技术和保障措施来保护个人隐私,同时生成和分析帮助客户推动人类健康成果的信息。必威官方在线必威手机APPIQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. To learn more, visitm.kurtisdurfey.com。
Click here to subscribe to Mobile Alerts for IQVIA.
Contactez-nousdèsAujourd'huipourdécouvrirles meilleures解决方案倒了。
We are pleased to speak with you during our standard business hours.
仅免费电话
+1 866 267 4479
对于国际电话,请在我们的免费列表。
Please use this form to reach out to our media team with inquiries. Thank you.